Nerolidol (Acyclic Sesquiterpene Alcohol · Penetration Enhancer · Anti-parasitic · Sedative)
| Compound | Nerolidol (Peruviol) |
| Chemical class | Terpenoid — Acyclic Sesquiterpene Alcohol |
| CAS | 7212-44-4 (trans); 3790-78-1 (cis) |
| Primary source | Melaleuca quinquenervia (niaouli), neroli (Citrus aurantium flowers), jasmine, camellia |
| Key applications | Antimicrobial, anti-parasitic, skin penetration enhancer, sedative, fragrance |
| Claim strength | Moderate |
| Typical form | Niaouli essential oil (up to 90% nerolidol); neroli oil constituent; tea plant/camellia co-constituent |
| Buy from Herbuno | Request availability and bulk pricing → |
Name origin: From neroli (the essential oil of bitter orange flowers, Citrus aurantium var. amara), where nerolidol was originally characterised. Also called peruviol from its early characterisation in Peruvian balsam. Nerolidol is an acyclic farnesol-related sesquiterpene alcohol — structurally a C15 equivalent of linalool (same carbon skeleton, extended by one isoprene unit). Traditional use: Neroli oil (from bitter orange flowers) has been used in European and Middle Eastern traditions for fragrance, anxiety relief, and skin care. Camellia/tea plant preparations (where nerolidol is a trace constituent) have extensive East Asian traditional use. Research trajectory: Nerolidol has attracted research for its skin penetration-enhancing properties (superior to many synthetic enhancers), anti-parasitic activity (effective against Plasmodium, Trypanosoma, Leishmania), antimicrobial effects, and sedative properties. It is among the most studied sesquiterpene alcohols for transdermal drug delivery applications. Commercial source: Not currently available as a standalone extract at commercial supplement scale from Herbuno. Contact Herbuno for availability assessment.
Evidence for Nerolidol Applications
Skin penetration enhancement: Nerolidol is one of the most potent natural transdermal penetration enhancers known, comparable to commercial synthetic enhancers (Azone) at equivalent concentrations. It disrupts stratum corneum lipid packing with high efficacy. Studies show nerolidol at 1–3% improves transdermal permeation of model drugs by 5–20-fold. Relevant for transdermal patch and topical pharmaceutical delivery applications. Claim strength: Moderate (in vitro and animal permeation data; human skin data limited).
Anti-parasitic: Nerolidol demonstrates potent activity against Plasmodium falciparum (malaria), Trypanosoma cruzi (Chagas disease), and Leishmania species in cell and animal models. The sesquiterpene alcohol disrupts parasite membrane integrity. Claim strength: Moderate (preclinical).
Antimicrobial: Broad-spectrum antimicrobial activity against S. aureus, E. coli, Candida, and food spoilage organisms. Relevant for natural preservation and topical antimicrobial applications. Claim strength: Moderate.
Sedative and anxiolytic: Nerolidol produces significant sedative effects in animal models (prolonged pentobarbital sleeping time, reduced locomotor activity) at doses of 25–100 mg/kg. The mechanism involves potentiation of GABAergic signalling. Relevant for sleep and relaxation formulations. Claim strength: Moderate (animal data).
Request availability and bulk pricing →
Browse Standardised Extract Powders →
Dosage & Formulator Specification
No established human oral supplement dose for nerolidol. Transdermal drug delivery: nerolidol at 1–3% w/v in formulation base for permeation enhancement. The two geometric isomers (cis- and trans-nerolidol) have different potency profiles — trans-nerolidol is generally considered the more bioactive form for antimicrobial and penetration-enhancing applications. Specify isomeric form and optical purity on CoA for pharmaceutical permeation applications. Contact Herbuno for nerolidol extract availability and specification.
Frequently Asked Questions — Nerolidol
How does nerolidol compare to bisabolol as a penetration enhancer?
Both are sesquiterpene alcohols with skin penetration-enhancing activity, but nerolidol is significantly more potent — enhancing permeation by 5–20-fold versus bisabolol’s 2–4-fold at comparable concentrations. Nerolidol disrupts stratum corneum lipid organisation more aggressively, which also means it carries a higher potential for skin irritation at high concentrations. For gentle enhancement in cosmeceuticals, bisabolol is preferred; for maximum penetration enhancement in pharmaceutical transdermal applications, nerolidol provides superior efficacy.
Is nerolidol found in cannabis/hemp?
Yes — nerolidol is one of the common terpenes found in cannabis and hemp essential oil fractions, alongside myrcene, linalool, and caryophyllene. It contributes to the characteristic woody-floral aroma of some cannabis cultivars and is discussed in cannabis entourage effect contexts for potential sedative and anti-parasitic contributions. For non-cannabis supplement applications, niaouli essential oil is the most concentrated commercial nerolidol source (up to 90% nerolidol).
What is niaouli and why is it the best commercial nerolidol source?
Melaleuca quinquenervia (niaouli, also called broad-leaved paperbark) is native to Australia and New Caledonia. Its essential oil contains up to 90% nerolidol alongside 1,8-cineole and viridiflorol, making it the most concentrated commercial natural nerolidol source available. Niaouli oil has been used in French pharmacopeia preparations as a wound antiseptic and respiratory decongestant, supporting the safety profile for topical and inhalation use.
Can nerolidol be used in a cannabis terpene-enhanced formulation?
Yes — nerolidol is appropriate for cannabis terpene blend formulations targeting sedative and anti-parasitic entourage effects. In hemp-derived CBD formulations, adding botanical nerolidol (from niaouli or other non-cannabis sources) can enhance the terpene profile without regulatory concerns associated with cannabis-derived terpenes in some markets. Standard fragrance allergen considerations apply for topical products.
Related compounds: Geraniol, Bisabolol, Farnesol, Linalool
Claim-strength scale – High = multiple human RCTs; Moderate = limited trials or strong preclinical convergence; Emerging = early-stage lab or animal data.
← HerbIQ Compound Index · HerbIQ P02: Extraction · HerbIQ P03: Delivery